Skip to main content
Top
Published in: BMC Women's Health 1/2019

Open Access 01-12-2019 | Tuberculosis | Case report

Fortuitous discovery of ganglionic tuberculosis after conservative treatment of breast cancer: a case report and review of the literature

Published in: BMC Women's Health | Issue 1/2019

Login to get access

Abstract

Background

Ganglionic tuberculosis is the most common extrapulmonary localization in Morocco. It is still a diagnostic and therapeutic problem especially when the infection is concomitant to the management of a cancer.

Case presentation

Here, we report the uncommon case of a fortuitous discovery of ganglionic tuberculosis in the anatomopathological analysis of an axillary node dissection after conservative treatment of breast cancer for a 29-year-old patient without medical history. Her file was discussed in a multidisciplinary consultation meeting during which several decisions were made. We decided to start her antituberculosis treatment then after three weeks her adjuvant chemotherapy with radiotherapy and hormone therapy. Furthermore, giver her young age, she had an oncogenetic consultation. Despite difficulties of therapeutic compliance, the patient completed her cancer treatments after two years, she also cured of her tuberculosis. Being in remission, she is still on hormone therapy and consults every 3-months as part of her follow-up.

Conclusions

Cancer and tuberculosis presenting simultaneously creates clinical and histopathological difficulties for differential diagnosis and for therapeutic decisions. Anticancer chemotherapy is not an obstacle in anti-tuberculosis treatment but the compliance of patients to receive both at the same time with the associated side effects is one to consider.
Literature
1.
go back to reference Geneva: WHO; 2010. World Health Organization. Fact Sheet No.104: Tuberculosis. Geneva: WHO; 2010. World Health Organization. Fact Sheet No.104: Tuberculosis.
2.
go back to reference Royaume du Maroc Ministère de la Santé Direction de l'Epidémiologie et de lutte contre les maladies. Programme national de lutte anti tuberculeuse - Edition Avril 2011. Royaume du Maroc Ministère de la Santé Direction de l'Epidémiologie et de lutte contre les maladies. Programme national de lutte anti tuberculeuse - Edition Avril 2011.
3.
go back to reference Sandhu R, et al. Microarray-based gene expression profiling for molecular classification of breast cancer and identification of new targets for therapy. Lab Medicine. 2010;41(6):364–72.CrossRef Sandhu R, et al. Microarray-based gene expression profiling for molecular classification of breast cancer and identification of new targets for therapy. Lab Medicine. 2010;41(6):364–72.CrossRef
4.
go back to reference Treatment of Tuberculosis: Guidelines. 4th edition. Geneva: World Health Organization; 2010. 3, Standard treatment regimens. Treatment of Tuberculosis: Guidelines. 4th edition. Geneva: World Health Organization; 2010. 3, Standard treatment regimens.
5.
go back to reference American Cancer Society. Breast Cancer Facts and Figures, vol. 2017–2018. Atlanta: American Cancer Society, Inc; 2017. American Cancer Society. Breast Cancer Facts and Figures, vol. 2017–2018. Atlanta: American Cancer Society, Inc; 2017.
6.
go back to reference Walters S, Maringe C, Butler J, et al. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000–2007: a population-based study. Br J Cancer. 2013;108:1195–208.CrossRef Walters S, Maringe C, Butler J, et al. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000–2007: a population-based study. Br J Cancer. 2013;108:1195–208.CrossRef
7.
go back to reference Salim EI, Moore MA, Al-Lawati JA, Al-Sayyad J, Bazawir A, Bener A, et al. Cancer epidemiology and control in the Arab world - past, present and future. Asian Pac J Cancer Prev. 2009;10(1):3–16.PubMed Salim EI, Moore MA, Al-Lawati JA, Al-Sayyad J, Bazawir A, Bener A, et al. Cancer epidemiology and control in the Arab world - past, present and future. Asian Pac J Cancer Prev. 2009;10(1):3–16.PubMed
8.
go back to reference Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.CrossRef Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.CrossRef
9.
go back to reference Parker PA, Youssef A, Walker S, Basen-Engquist K, Cohen L, Gritz ER, Wei QX, Robb GL. Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancer. Ann Surg Oncol. 2007;14:3078–89.CrossRef Parker PA, Youssef A, Walker S, Basen-Engquist K, Cohen L, Gritz ER, Wei QX, Robb GL. Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancer. Ann Surg Oncol. 2007;14:3078–89.CrossRef
10.
go back to reference Doridot V, et al. Breast-conserving therapy for breast cancer. Cancer/Radiothérapie. 2004;8(1):21–8.CrossRef Doridot V, et al. Breast-conserving therapy for breast cancer. Cancer/Radiothérapie. 2004;8(1):21–8.CrossRef
11.
go back to reference Călăraşu C, et al. Lymph node tuberculosis after melanoma treatment – sometimes the patient is lucky. Rom J Morphol Embryol. 2016;57(4):1383–8.PubMed Călăraşu C, et al. Lymph node tuberculosis after melanoma treatment – sometimes the patient is lucky. Rom J Morphol Embryol. 2016;57(4):1383–8.PubMed
12.
go back to reference Safdar A, Armstrong D. Infectious morbidity in critically ill patients with cancer. Crit Care Clin. 2001;17:531–70 vii–viii.CrossRef Safdar A, Armstrong D. Infectious morbidity in critically ill patients with cancer. Crit Care Clin. 2001;17:531–70 vii–viii.CrossRef
13.
go back to reference Seo GH, Kim MJ, Seo S, et al. Cancer-specific incidence rates of tuberculosis: A 5-year nationwide population-based study in a country with an intermediate tuberculosis burden. S. Levin. A, ed. Medicine. 2016;95(38):e4919.CrossRef Seo GH, Kim MJ, Seo S, et al. Cancer-specific incidence rates of tuberculosis: A 5-year nationwide population-based study in a country with an intermediate tuberculosis burden. S. Levin. A, ed. Medicine. 2016;95(38):e4919.CrossRef
14.
go back to reference Kamboj M, Sepkowitz KA. The risk of tuberculosis in patients with cancer. Clin Infect Dis. 2006;42:1592–5.CrossRef Kamboj M, Sepkowitz KA. The risk of tuberculosis in patients with cancer. Clin Infect Dis. 2006;42:1592–5.CrossRef
15.
go back to reference De La Rosa GR, Jacobson KL, Rolston KV, et al. Mycobacterium tuberculosis at a comprehensive cancer centre: active disease in patients with underlying malignancy during 1990–2000. Clin Microbiol Infect. 2004;10:749–52.CrossRef De La Rosa GR, Jacobson KL, Rolston KV, et al. Mycobacterium tuberculosis at a comprehensive cancer centre: active disease in patients with underlying malignancy during 1990–2000. Clin Microbiol Infect. 2004;10:749–52.CrossRef
16.
go back to reference McDermott W. Microbial persistence. Yale J Biol Med. 1958;30(4):257–91.PubMed McDermott W. Microbial persistence. Yale J Biol Med. 1958;30(4):257–91.PubMed
17.
go back to reference Stead WW. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am Rev Respir Dis. 1967;95(5):729–45.PubMed Stead WW. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am Rev Respir Dis. 1967;95(5):729–45.PubMed
18.
go back to reference Vento S, Lanzafame M. Tuberculosis and cancer: a complex and dangerous liaison. Lancet Oncol. 2011;12(6):520–2.CrossRef Vento S, Lanzafame M. Tuberculosis and cancer: a complex and dangerous liaison. Lancet Oncol. 2011;12(6):520–2.CrossRef
19.
go back to reference Baslaim MM, Al-Ghamdi MA, Al-Numani TS, Ashour AS, Al-Amoudi SA. Tuberculosis in 7 breast cancer cases: diagnostic and therapeutic challenges. J Mycobac Dis. 2013;3(3):135. Baslaim MM, Al-Ghamdi MA, Al-Numani TS, Ashour AS, Al-Amoudi SA. Tuberculosis in 7 breast cancer cases: diagnostic and therapeutic challenges. J Mycobac Dis. 2013;3(3):135.
Metadata
Title
Fortuitous discovery of ganglionic tuberculosis after conservative treatment of breast cancer: a case report and review of the literature
Publication date
01-12-2019
Published in
BMC Women's Health / Issue 1/2019
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-019-0780-8

Other articles of this Issue 1/2019

BMC Women's Health 1/2019 Go to the issue